RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Pantoprazole

Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux..., Maintenance of Healing of Erosive Esophagitis, Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome

Indications

  • Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux...
  • Maintenance of Healing of Erosive Esophagitis
  • Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome

Adult dosing

  • erosive esophagitis: dose: 40; unit: mg; route: PO; interval: once daily for up to 8 weeks; fixed: true; labelExcerpt: Adults 40 mg Once Daily for up to 8 wks

Pediatric dosing

  • erosive esophagitis 15 to 40kg: dose: 20; unit: mg; route: PO; interval: once daily up to 8 weeks (age >=5 y, 15 to <40 kg; 40 mg if >=40 kg); fixed: true; labelExcerpt: Children (5 years and older) ≥ 15 kg to < 40 kg 20 mg Once Daily for up to 8 wks

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Consult pharmacy/current label

Contraindications

  • Hypersensitivity to formulation or substituted benzimidazoles
  • Patients receiving rilpivirine-containing products

Clinical pearls

  • Do not split, chew, or crush delayed-release tablets.
  • Use the lowest dose and shortest duration of therapy appropriate for the condition.
  • Monitor for C. difficile-associated diarrhea and potential hypomagnesemia.
  • Risk of osteoporosis-related bone fractures increases with long-term, multiple-daily dose therapy.

Source and review

  • DailyMed label (pantoprazole sodium), Set ID 410d5577-e50a-44f3-aaa8-fbf391a0c261, effective 2026-10-13. Last reviewed: 2026-11-11